The analysis of the expression of these genes in NSCLC cells after the treatment with SFRE indicated the downregulation of TK1 and TYMS (Figure 7B) which may explain, at least partially, the observed synergism in the inhibition of cell proliferation between SFRE and cisplatin. Here, TK1 is linked to non-small cell lung carcinoma.